AAAAAA

   
Results: 1-2 |
Results: 2
SEROQUEL(TM) (ICI-204-636) - A NOVEL, ATYPICAL ANTIPSYCHOTIC - EFFICACY AND SAFETY RESULTS FROM 2 PHASE-II, MULTICENTER, PLACEBO-CONTROLLEDCLINICAL-TRIALS
Authors: ARVANITIS L MILLER BG LINK CGG
Citation: L. Arvanitis et al., SEROQUEL(TM) (ICI-204-636) - A NOVEL, ATYPICAL ANTIPSYCHOTIC - EFFICACY AND SAFETY RESULTS FROM 2 PHASE-II, MULTICENTER, PLACEBO-CONTROLLEDCLINICAL-TRIALS, Schizophrenia research, 15(1-2), 1995, pp. 142-142
ICI-204,636, A NOVEL, ATYPICAL ANTIPSYCHOTIC - EARLY INDICATION OF SAFETY AND EFFICACY IN PATIENTS WITH CHRONIC AND SUBCHRONIC SCHIZOPHRENIA
Authors: FABRE LF ARVANITIS L PULTZ J JONES VM MALICK JB SLOTNICK VB
Citation: Lf. Fabre et al., ICI-204,636, A NOVEL, ATYPICAL ANTIPSYCHOTIC - EARLY INDICATION OF SAFETY AND EFFICACY IN PATIENTS WITH CHRONIC AND SUBCHRONIC SCHIZOPHRENIA, Clinical therapeutics, 17(3), 1995, pp. 366-378
Risultati: 1-2 |